Followers | 25 |
Posts | 1899 |
Boards Moderated | 0 |
Alias Born | 06/15/2007 |
Tuesday, March 07, 2023 1:31:05 PM
DUBLIN, Ireland and BRIDGEWATER, N.J., March 05, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome (<12 months before randomization). This post-hoc analysis showed that icosapent ethyl (IPE) substantially and significantly reduced the risk of first and total ischemic events by 37% and 36% respectively in patients with recent acute coronary syndrome (ACS) without increasing bleeding, supporting early initiation of IPE after ACS. The data were presented at the American College of Cardiology’s 72nd Annual Scientific Session together with the World Heart Federation’s World Congress of Cardiology in New Orleans, LA.
https://healthstockshub.com/news/nasdaq/amrn/amarin-announces-new-reduce-it-data-at-acc-23-wcc-showing-benefit-of-vascepa-vazkepa-icosapent-ethyl-in-high-risk-patients-with-a-recent-acute-coronary-syndrome-event
Recent AMRX News
- Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab) • Business Wire • 07/01/2024 12:00:00 PM
- Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar • Business Wire • 07/01/2024 12:00:00 PM
- Amneal Releases 2023 Environmental, Social and Governance Report • Business Wire • 06/28/2024 12:00:00 PM
- Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies • Business Wire • 06/05/2024 12:00:00 PM
- Amneal to Participate at Upcoming Investor Conference • Business Wire • 05/22/2024 08:05:00 PM
- Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California • Business Wire • 05/22/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 07:13:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:45:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:45:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:43:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:42:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:18:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:35:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:31:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:28:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:19:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:17:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/03/2024 10:14:36 AM
- Amneal Reports First Quarter 2024 Financial Results • Business Wire • 05/03/2024 10:00:00 AM
- Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose • Business Wire • 04/24/2024 12:00:00 PM
- Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine • Business Wire • 04/16/2024 12:00:00 PM
- Amneal to Report First Quarter 2024 Results on May 3, 2024 • Business Wire • 04/10/2024 12:00:00 PM
- Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 • Business Wire • 03/28/2024 08:05:00 PM
- Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension • Business Wire • 03/25/2024 08:05:00 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM